For press inquiries click here to contact us.
Everly Health
Everlywell acquires two healthcare companies and forms parent Everly Health
Maze Therapeutics
Exclusive: Maze unveils their $191M pipeline, taking on Vertex and two long-sought conditions
insitro
Insitro raises $400M for machine learning-powered drug discovery efforts
Remix Therapeutics
Remix Therapeutics debuts with $81M to ‘reprogram’ disease-causing RNA
Everly Health
Demand for at-home testing propels Everlywell to $175M in new funding
Maze Therapeutics
Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle
GRAIL, Inc.
Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal
Evonetix
Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices
Lyell Immunopharma
Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors
Please see important disclaimers in the Terms section.
